このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Dynavax Technologies バランスシートの健全性
財務の健全性 基準チェック /56
Dynavax Technologiesの総株主資本は$618.5M 、総負債は$223.0Mで、負債比率は36.1%となります。総資産と総負債はそれぞれ$986.6Mと$368.1Mです。
主要情報
36.1%
負債資本比率
US$222.98m
負債
| インタレスト・カバレッジ・レシ オ | n/a |
| 現金 | US$723.54m |
| エクイティ | US$618.48m |
| 負債合計 | US$368.09m |
| 総資産 | US$986.57m |
財務の健全性に関する最新情報
Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06
These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Recent updates
Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Dynavax And TLR Biology: Long-Delayed But Outstanding Success
Oct 16These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Reasonably Well
Oct 02Upgrade: Analysts Just Made A Meaningful Increase To Their Dynavax Technologies Corporation (NASDAQ:DVAX) Forecasts
Aug 10Dynavax: Earnings This Year Ought To Surprise To The Upside
Aug 01財務状況分析
短期負債: DVAXの 短期資産 ( $851.3M ) が 短期負債 ( $56.0M ) を超えています。
長期負債: DVAXの短期資産 ( $851.3M ) が 長期負債 ( $312.1M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: DVAX総負債よりも多くの現金を保有しています。
負債の削減: DVAXの負債対資本比率は、過去 5 年間で407%から36.1%に減少しました。
債務返済能力: DVAXの負債は 営業キャッシュフロー によって 十分にカバー されています ( 25.2% )。
インタレストカバレッジ: DVAXの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。